SavedAdd your journal

Journals / Türkiye Çocuk Hastalıkları Dergisi / 2020 / Cilt: 14 - Sayı: 2

A Comparison of Vitamin D Levels in Chidren with Language and Speech Disorders and Healthy Children in the Turkish Population

Sağlıklı Çocuklarla, Dil ve Konuşma Bozukluğu Olan Çocuklar Arasında Vitamin D Düzeyinin Karşılaştırılması

Saime SAĞIROĞLU
Pages
158–163
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum vitamin D values were found to be statistically significantly (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to investigate the relationship between vitamin D [25(OH)] values with the language andspeech disorders in children.Material and Methods: A total of 200 children were included in the study, comprising 124 children, with stuttering(n=62), functional language disorder (n=40) and articulation disorder (n=22) as the patient group and a control groupof 76 healthy children.
📊
Key Findings & Data:Vitamin D levels were examined in blood samples taken from both the patient group and thecontrol group.Results: Serum vitamin D levels were determined as 23.68 ± 10.95 in patients with articulation disorder, 17.82 ± 8.28in patients with functional language disorder, 23.36 ± 10.01 in patients with stuttering, and 26.01 ± 7.4 in the controlgroup.
💡
Conclusion & Impact:Serum vitamin D values were found to be statistically significantly (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to investigate the relationship between vitamin D [25(OH)] values with the language andspeech disorders in children.Material and Methods: A total of 200 children were included in the study, comprising 124 children, with stuttering(n=62), functional language disorder (n=40) and articulation disorder (n=22) as the patient group and a control groupof 76 healthy children. Vitamin D levels were examined in blood samples taken from both the patient group and thecontrol group.Results: Serum vitamin D levels were determined as 23.68 ± 10.95 in patients with articulation disorder, 17.82 ± 8.28in patients with functional language disorder, 23.36 ± 10.01 in patients with stuttering, and 26.01 ± 7.4 in the controlgroup. Serum vitamin D values were found to be statistically significantly (p

Özet

Amaç: Bu çalışmada, dil ve konuşma bozukluğu olan çocuklar ile vitamin D (25(OH)D3) düzeyi arasındaki ilişki araştırıldı. Gereç ve Yöntemler: Toplam 200 çocuk çalışmaya alındı. Hasta olarak alınan 124 çocukta; kekemelik (n=62), fonksiyonel dil gelişim bozukluğu (n=40) ve artikülasyon bozukluğu (n=22) vardı. Kontrol grubuna 76 sağlıklı çocuk alındı. Hastalarda ve sağlıklı çocuklarda plazmada vitamin D seviyesine bakıldı. Bulgular: Vitamin D seviyesi; kekemeliği olanlarda 23.36±10.01, fonksiyonel dil gelişim bozukluğu olanlarda 17.82±8.28, artikülasyon bozukluğu olanlarda 23.68±10.95, kontrol grubunda 26.01±7.4 olarak saptandı. Artikülasyon ve kekemelik ile kontrol grubu arasında vitamin D açısından anlamlı fark bulunmadı. Fonksiyonel dil gelişim bozukluğu olan çocuklarda, sağlıklı gruba göre vitamin D değeri daha düşüktü ve istatistiksel olarak anlamlı bir fark saptandı (p

🔖

Cite This Article

SAĞIROĞLU, S. (2022). A Comparison of Vitamin D Levels in Chidren with Language and Speech Disorders and Healthy Children in the Turkish Population. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 14 - Sayı: 2, 158–163. https://ajindex.com/articles/627079

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Silverman FH.Stuttering and Other Fluency Disorders. Illinois: Waveland Press. 2004 2. Maria-Mengel MR, Martins Linhares MB. Risk factors for infant developmental problems. Rev Lat Am Enfermagem 2007;15:837– 42. 3. Samra HA, Mcgrath JM, Wehbe M. An integrated review of developmental outcomes and late-preterm birth. J Obstet Gynecol Neonatal Nurs 2011;40:399–411. 4. Hall NE. Developmental Language Disorder. Semin Pediatr Neurol 1997;4:77-85. 5. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080-6. 6. Holick MF. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004;79:362-71. 7. Lemire JM, Archer DC. 1.25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991;87:1103-7. 8. Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, Atkinson SA, Josse RG, Feldman S, Kline GA, Rosen C. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:610-8. 9. Kiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a Neuroactive Substance:Review. Scientific World Journal 2006;26;125-139. 10. Sutherland MK, Wong L, Somerville MJ, Yoong LK, Bergeron C, Parmentier M, et al. Reduction of calbindin-24k mRNA levels in Alzheimer as compared to Huntington hippocampus. Brain Res Mol Brain Res 1993;18:32-42. 11. Schoenrock SA, Tarantino LM. Developmental vitamin D deficiency and schizophrenia: the role of animal models. Genes Brain Behav 2016;15:45-61. 12. McGrath J, Eyles D, Mowry B, Yolken R, Buka S. Low maternal vitamin D as a risk factor for schizophrenia:a pilot study using banked sera. Schizophr Res 2003;63:73-8. 13. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007;460:202-5. 14. American Psychiatric Association. Diagnostic criteria from DSM-IVTR. Washington DC: American Psychiatric Association 2000;370- 381. 15. Luu TM, Vohr BR, Schneider KC, Katz KH, Tucker R, Allan WC, et al. Trajectories of receptive language development from 3 to 12 years pf age for very preterm children. Pediatrics 2009;124;333- 41. 16. Martson L, Peacock JL, Calvert SA, Greenough A, Marlow N. Factors affecting vocabulary acquisition at age 2 in children born between 23 and 28 weeks’ gestation. Dev Med C